CRISPR Therapeutics AG (CRSP)

54.14 -1.56 (-2.80%) USD  |  NASDAQ  |  Sep 25, 10:31
More

CRISPR Therapeutics Cash and Short Term Investments (Quarterly) : 2.365B for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 2.365B
March 31, 2026 2.442B
December 31, 2025 1.983B
September 30, 2025 1.919B
June 30, 2025 1.725B
March 31, 2025 1.859B
December 31, 2024 1.904B
September 30, 2024 1.936B
June 30, 2024 2.002B
March 31, 2024 2.108B
December 31, 2023 1.694B
September 30, 2023 1.740B
June 30, 2023 1.768B
March 31, 2023 1.883B
December 31, 2022 1.815B
September 30, 2022 1.896B
June 30, 2022 2.065B
March 31, 2022 2.221B
December 31, 2021 2.379B
September 30, 2021 2.477B
June 30, 2021 2.589B
Date Value
March 31, 2021 1.806B
December 31, 2020 1.690B
September 30, 2020 1.366B
June 30, 2020 945.07M
March 31, 2020 889.71M
December 31, 2019 943.77M
September 30, 2019 629.72M
June 30, 2019 427.88M
March 31, 2019 437.55M
December 31, 2018 456.65M
September 30, 2018 487.30M
June 30, 2018 319.74M
March 31, 2018 341.77M
December 31, 2017 239.76M
September 30, 2017 253.52M
June 30, 2017 272.26M
March 31, 2017 288.87M
December 31, 2016 315.52M
September 30, 2016 228.61M
June 30, 2016 246.85M
March 31, 2016 200.60M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. 7.863B
Basilea Pharmaceutica AG --
Santhera Pharmaceuticals Holding AG --
BeOne Medicines Ltd. 5.259B
AC Immune SA 93.42M